您的位置: 专家智库 > >

国家自然科学基金(81173110)

作品数:7 被引量:27H指数:3
相关作者:杨为民杜晓华李佳勋杨为民赵继坤更多>>
相关机构:昆明医科大学更多>>
发文基金:国家自然科学基金云南省重点新产品开发计划更多>>
相关领域:医药卫生生物学更多>>

文献类型

  • 7篇中文期刊文章

领域

  • 6篇医药卫生
  • 1篇生物学

主题

  • 5篇SCUTEL...
  • 3篇PKG
  • 2篇REOXYG...
  • 2篇HYPOXI...
  • 1篇血性
  • 1篇药理
  • 1篇药理学
  • 1篇药物
  • 1篇药物研究
  • 1篇药物研究进展
  • 1篇一般药理
  • 1篇一般药理学
  • 1篇异佛司可林
  • 1篇治疗药
  • 1篇治疗药物
  • 1篇缺血
  • 1篇缺血性脑卒中
  • 1篇卒中
  • 1篇脑卒中
  • 1篇发病

机构

  • 2篇昆明医科大学

作者

  • 1篇杨之斌
  • 1篇付健健
  • 1篇赵继坤
  • 1篇杜晓华
  • 1篇杨为民
  • 1篇杨为民
  • 1篇李佳勋

传媒

  • 2篇中国药理学与...
  • 1篇医学信息(医...
  • 1篇Chines...
  • 1篇Chines...
  • 1篇昆明医科大学...
  • 1篇Natura...

年份

  • 1篇2021
  • 1篇2019
  • 3篇2015
  • 2篇2014
7 条 记 录,以下是 1-7
排序方式:
Scutellarin protects human cardiac microvascular endothelial cells with hypoxia-reoxygenation injury via JAK2/STAT3 signal pathway被引量:2
2019年
Objective: To investigate the antagonistic cell injury effect and molecular mechanism of scutellarin(SCU)in hypoxia reoxygenation(HR) treated human cardiac microvascular endothelial cells(HCMECs).Methods: The method of 12 h hypoxia following by 12 h reoxygenation was used to culture HCMECs in vitro to built cell injury model. The groups were divided into control group, model(HR) group, and HR + SCU(0.1 μmol/L, 1 μmol/L, and 10 μmol/L) group. The cell viability was determined by MTT, and oxidative stress was detected by malondialdehyde(MDA) levels by biochemical assay kit. Protein expression of JAK2/p-JAK2 and STAT3/p-STAT3 were evaluated by Western blot.Results: The results of MTT and MDA showed that HR decreased the cell viability(P < 0.05) and increased MDA level significantly(P < 0.05), SCU played a contrary role in these processes. Western blot analysis indicates that, the expression of JAK2 and p-JAK2, STAT3, and p-STAT3 were increased in model group when compared with control group(P < 0.05); Compared with model group, their expression were reduced by SCU(P < 0.05).Conclusion: SCU took a protective effect on HR-treated HCMECs, and the molecular mechanism may be associated with the inhibition of JAK2/STAT3 signal transduction pathway.
Chen ChenZhi-ying WengYou-lan WangChang-bo ZhengYang LiJian YangZe-lan DaiBai-xi JiChuang XiaoWei-min Yang
关键词:VIABILITYREOXYGENATIONJAK2-STAT3SCUTELLARIN
Scutellarin Reduces Cerebral Ischemia Reperfusion Injury Involving in Vascular Endothelium Protection and PKG Signal被引量:2
2021年
Flavonoid glycoside scutellarin(SCU)has been widely applied in the treatment of cerebral ischemic diseases in China.In this article,we conducted research on the working mechanisms of SCU in hypoxia reoxygenation(HR)injury of isolated cerebral basilar artery(BA)and erebral ischemia reperfusion(CIR)injury in rat models.In isolated rat BA rings,HR causes endothelial dysfunction(ED)and acetylcholine(ACh)induces endothelium-dependent vasodilation.The myography result showed that SCU(100μM)was able to significantly improve the endothelium-dependent vasodilation induced by Ach.However,SCU did not affect the ACh-induced relaxation in normal BA.Further studies suggested that SCU(10-1000μM)dose-dependently induced relaxation in isolated BA rings which were significantly blocked by the cGMP dependent protein kinase(PKG)inhibitor Rp-8-Br-cGMPs(PKGI-rp,4μM).Pre-incubation with SCU(500μM)reversed the impairment of endothelium-dependent vasodilation induced by HR,but the reversing effect was blocked if PKGI-rp(4μM)was added.The brain slice staining test in rats’model of middle cerebral artery occlusion(MCAO)induced CIR proved that the administration of SCU(45,90 mg/kg,iv)significantly reduced the area of cerebral infarction.The Western blot assay result showed that SCU(45 mg/kg,iv)increased brain PKG activity and PKG protein level after CIR surgery.In conclusion,our findings suggested that SCU possesses the ability of protecting brain cells against CIR injury through vascular endothelium protection and PKG signal.
Ya-Juan ChenChen ChenMeng-Yuan LiQing-Qing LiXiu-Juan ZhangRong HuangXing-Wei ZhuChun-Yun BaiLiu-Yi ZhangPei-Hua PengWei-Min Yang
关键词:SCUTELLARINPKG
Scutellarin attenuates endothelium-dependent aasodilation impairment induced by hypoxia reoxygenation, through regulating the PKG signaling pathway in rat coronary artery被引量:6
2015年
Scutellarin(SCU), a flavonoid from a traditional Chinese medicinal plant. Our previous study has demonstrated that SCU relaxes mouse aortic arteries mainly in an endothelium-depend-ent manner. In the present study, we investigated the vasoprotective effects of SCU against HR-induced endothelial dysfunction(ED) in isolated rat CA and the possible mechanisms involving cyclic guanosine monophosphate(c GMP) dependent protein kinase(PKG). The isolated endothelium-intact and endothelium-denuded rat CA rings were treated with HR injury. Evaluation of endothelium-dependent and-independent vasodilation relaxation of the CA rings were performed using wire myography and the protein expressions were assayed by Western blotting. SCU(10–1 000 μmol·L-1) could relax the endothelium-intact CA rings but not endothelium-denuded ones. In the intact CA rings, the PKG inhibitor, Rp-8-Br-c GMPS(PKGI-rp, 4 μmol·L-1), significantly blocked SCU(10–1 000 μmol·L-1)-induced relaxation. The NO synthase(NOS) inhibitor, NO-nitro-L-arginine methylester(L-NAME, 100 μmol·L-1), did not significantly change the effects of SCU(10–1 000 μmol·L-1). HR treatment significantly impaired ACh-induced relaxation, which was reversed by pre-incubation with SCU(500 μmol·L-1), while HR treatment did not altered NTG-induced vasodilation. PKGI-rp(4 μmol·L-1) blocked the protective effects of SCU in HR-treated CA rings. Additionally, HR treatment reduced phosphorylated vasodilator-stimulated phosphoprotein(p-VASP,phosphorylated product of PKG), which was reversed by SCU pre-incubation, suggesting that SCU activated PKG phosphorylation against HR injury. SCU induces CA vasodilation in an endothelium-dependent manner to and repairs HR-induced impairment via activation of PKG signaling pathway.
CHEN Ya-JuanWANG LeiZHOU Guang-YuYU Xian-LunZHANG Yong-HuiHU NaLI Qing-QingCHEN ChenQING ChenLIU Ying-TingYANG Wei-Min
关键词:SCUTELLARINRAT
佛司可林及异佛司可林的一般药理学初步研究被引量:5
2014年
目的观察佛司可林(forskolin,FSK)、异佛司可林(isoforskolin,ISOF)对SD大鼠的心血管系统、呼吸系统的影响.方法 (1)将50只SD大鼠按雌雄各半随机分为5个处理组,即对照组(Control)、FSK及ISOF低、高剂量组(2、6 mg/kg),每组n=10.(2)动物颈总动脉置管,连接压力换能器及多道生理记录仪,记录大鼠心率(heart rate,HR)、呼吸频率(breathing rate,BR)、收缩压(systolic blood pressure,SBP)、平均动脉压(mean arterypressure,MAP)、舒张压(diastolic blood pressure,DBP).待各监测指标平稳后给予相应记录,十二指肠给药,分别记录大鼠给药前、给药后0.5 h、1 h、1.5 h、2 h和2.5 h的心率、呼吸频率、收缩压、平均动脉压、舒张压情况.结果与给药前比较,各处理组在给药后0.5 h、1 h、1.5 h、2 h和2.5 h的心率、呼吸频率、收缩压、平均动脉压、舒张压均无明显变化,各处理组均差异无统计学意义(P>0.05);与对照组比较,各处理组在给药前、给药后0.5 h、1 h、1.5 h、2 h和2.5 h的心率、呼吸频率、收缩压、平均动脉压、舒张压均差异无统计学意义(P>0.05),各处理组差异无统计学意义(P>0.05).结论一般药理学研究表明,FSK及ISOF低、高剂量组(2、6mg/kg)对SD大鼠的心率、呼吸频率、收缩压、平均动脉压、舒张压均无明显影响.
赵继坤杨为民杨之斌李佳勋付健健
关键词:佛司可林异佛司可林一般药理学
缺血性脑卒中的病理机制及药物研究进展被引量:12
2014年
缺血性脑卒中已成为威胁人类健康的重要因素,其发病率和死亡率呈不断上升趋势,因此探讨缺血性脑卒中的发病机理及其药物研究,对于预防和治疗该病具有重要的意义。本文阐述了缺血性脑卒中的发病机制及治疗药物的研究进展。
马聪吉杜晓华杨为民
关键词:缺血性脑卒中发病机制治疗药物
Protective effects of scutellarin on vascular dysfunction caused by hypertension in SHR rats
2015年
OBJECTIVE To investigate the effect of scutellarin(SCU),which is the main effective component of Erigeron breviscapus(Vant.)Hand-Mazz native to Yunnan in China,on vascular dysfunction(VD)of cardiac coronary artery(CA)and cerebral basilar artery(BA)caused by hypertension in SHR rats.METHODS 1.BA and CA vesselsrings from 40 weeks of SHR rats were isolated and equilibrated in organ bath with MOPS-PSS buffer and ring tension was recorded,comparing with a normal control of WKY rats.SCU was treated accumulatively after pre-contracted with vasoconstrictor U46619(1μmol·L-1).2.ACH and SNP were treated accumulatively after pre-incubation with SCU(300μmol·L-1,100μmol·L-1)and pre-contracted by U46619(1μmol·L-1),K+60mmol·L-1,respectively.While U46619 was added accumulatively to BA/CA rings pre-incubated with SCU(300and 100μmol·L-1).ACH-induced relaxation rate was to evaluate endothelium-dependent relaxation,and SNP-induced relaxation rate to evaluate the artery non-endothelium-dependent relaxation.RESULTS SCU significantly dilated both BA and CA rings pre-contracted by U46619 in old rats.EC50 value of SCU in WKY ratswas less than that in SHR(P<0.05),which showing VD of CA and BA in SHR rats.Compared with WKY group,ACH relaxation curve of SHR group shifted to the right,suggesting that hypertension induced VD.When SCU 300μmol·L-1 pre-treated CA groups and SCU 100μmol·L-1 pre-treated BA groups,EC50 to ACH was significantly lower(P<0.05).Likewise,the vasodilatation of CA/BA rings to SNP was also improved obviously when pre-treated with SCU,and Emax to SNP was decreased significantly(P<0.05).Moreover,EC50 to U46619was significantly lower when pre-treated by SCU.CONCLUSION In SHR rats,SCU antagonized U46619 on CA/BA rings in a noncompetitive manner.Furthermore,SCU should appear to protect VD induced by hypertension.
Qing-qingLIZhi-yingWENGMinZHANGChenCHENXiao-huaDUPei-huaPENGWen-juanWUJunZHANGWei-minYANG
关键词:SCUTELLARINSHRCORONARYARTERYBASILARARTERYVAS
Effects of scutellarin on PKG in HCMECs after hypoxia roxygenation
2015年
OBJECTIVE This study discusses the effects of scutellarin(SCU),which is one of effective component of Erigeron breviscapus(Vant.)Hand-Mazz,on cGMP dependent protein kinase(PKG)in human cardiac microvascular endothelial cells(HCMECs)after hypoxia roxygenation(HR).METHODS Based on a model of HCMECs cells with HR injury,cell viability is examined by MTT assay.Protein expression of PKG is analyzed by Western blotting and its enzyme activity is investigated by ELISA technology.RESULTS The results of MTT assay- indicate that SCU(1,10μmol·L1)could protect HCMECs against HR injury.SCU(0.1,1 and 10μmol·L-1)canenhance PKG-I expression in control and HR injury cells.Furthermore,SCU(1,10μmol·L-1 significantly increase PKG activity in control cells(P<0.01),and also SCU(100μmol·L-1)appears similar on enzyme activity in HR injury cells(P <0.05).CONCLUSION SCU appears protective effects on endothelial cells against HR damage.While its mechanisms may be related to the influence of SCU on PKG activity in HCMECs.
YangLIZhi-yingWENGMinZHANGChenCHENXiao-huaDUPei-huaPENGWen-juanWUXuanLIUWei-minYANG
关键词:SCUTELLARINHYPOXIAPKGHUMANCARDIAC
共1页<1>
聚类工具0